Interdisciplinarity and Digitalization in Economic Security Provision of the Pharmaceutical Industry

In the context of global polycrises and digital transformation, the pharmaceutical industry is becoming a critically important element in the economic and technological security of the country. The examples of the COVID-19 pandemic and sanctions pressure demonstrate the mechanisms of polycrises, their impact on the pharmaceutical industry, and the need to transform strategic thinking. The solutions lie in various disciplines. The study examines a new methodological approach to researching the economic security of the industry, based on the concepts of interdisciplinarity and the digital economy. Through the “Mode 2” concept, the need to move from traditional linear analysis to scientific life built around the practice of ensuring the economic security of the pharmaceutical industry is demonstrated. Digitalization has a transformative impact on the pharmaceutical industry while also being a source of new threats and a basis for the formation of integrative analytical approaches. The complexity of digital supply chains, data vulnerability, and dependence on global IT infrastructure create qualitatively different risk contours that require interdisciplinary analysis. At the same time, digital tools such as big data, artificial intelligence, and digital twins make it possible to build comprehensive methodologies for economic security assessment, combining technological, economic, and regulatory parameters into a single cognitive framework. It was found that the concept of economic security as an integrative environment is capable not only of combining diverse knowledge but also of serving as an operational platform for decision-making in conditions of growing uncertainty. Particular attention is paid to the institutionalization of integrated research platforms and the development of a new cognitive model of interdisciplinary specialists’ activities, the “thinking interface,” as the ability to connect the logic of different areas of knowledge (technological, economic, and regulatory). The formation of a new educational trajectory for the training of such specialists is suggested. The results of the study show that the economic security of pharmaceuticals in turbulent conditions is not only an object of analysis but also a tool for strategic action. It is at this point that the practical experience and responsibility of researchers must intersect, forming the architecture of a sustainable future for the industry.